TTTheogene Twagirumugabe

Theogene Twagirumugabe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Theogene Twagirumugabe has a total of 170 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bypassing the Cash Desk for Patient Payments: Asynchronous Mobile Money Integration and an 8-Month Evaluation of Payment Cycle Time at a Rwandan Tertiary Hospital (Preprint)

    by Djibril Mbarushimana, Jean Damascene Gatera, Yaqub Muganga, Oswald Benimana, Jean Nepomuscene Ntawurushimana, Felix Niyomugabo, Clarisse Kayitasire, Nsengiyumva Emmanuel, Adolphe Hitimana, Kabanguka Prosper, et al.

  • Open Access

    Eliminating Patient Queues for Payment via Asynchronous Mobile Money Integration: Architecture and an Eight-Month Performance Evaluation at a Rwandan Tertiary Hospital (Preprint)

    by Djibril Mbarushimana, Jean Damascene Gatera, Yaqub Muganga, Oswald Benimana, Jean Nepomuscene Ntawurushimana, Felix Niyomugabo, Clarisse Kayitasire, Nsengiyumva Emmanuel, Adolphe Hitimana, Kabanguka Prosper, et al.

    BACKGROUND Patient payment queuing at hospital cashier desks is a persistent operational challenge in resource-limited healthcare settings. In October 2025, the University Teaching Hospital of Butare (CHUB), a public tertiary referral centre in Rwanda, integrated an asynchronous Mobile Money payment module with its OpenClinic GA hospital management information system (HMIS) through the Irembo payment gateway, as an unfunded quality improvement initiative. OBJECTIVE To describe the integration architecture and quantify its impact on patient payment cycle time, channel adoption, and transaction reliability over eight months of routine operation. METHODS The architecture is described from direct analysis of the deployed production source code. Performance was evaluated by retrospective analysis of all closed invoices for prepaid services (laboratory, imaging, pharmacy) from 1 October 2025 to 31 May 2026. Payment cycle time was defined as the interval from bill creation to payment confirmation; transactions exceeding 24 hours were excluded. RESULTS The integration implements a fully asynchronous, non-blocking model with dual trigger pathways (patient-initiated SMS and staff-initiated HMIS form) and a four-step Irembo API workflow. Across 146,203 invoiced episodes, Mobile Money adoption grew from 3.8% to 20.9%. Among 131,037 within-24-hour transactions, median payment cycle time was 5 minutes for Mobile Money versus 72 minutes for cash, a 93.1% reduction. The system processed 44,216 transactions with a 97.9% success rate; all failure causes were identified and resolved. Insurer paper-documentation requirements were the principal structural ceiling on adoption. CONCLUSIONS Asynchronous mobile money integration delivered large, sustained reductions in patient payment waiting time and provides a reproducible reference model for sub-Saharan African hospitals.

  • Open Access

    Digital Integration of CLSI and EUCAST Guidelines in Antimicrobial Susceptibility Testing Reporting: A Pre and Post Implementation Study at a Rwandan Tertiary Hospital (Preprint)

    by Djibril Mbarushimana, Taofeek Tope Adegboyega, Gatera Jean Damascene, Muritala Issa Bale, Buregeya Jean Damascene, Kayitesi Marie Francoise, Itangishaka Innocent, Theogene Bahizi, Alex Rugamba, Rasheed Omotayo Adeyemo, et al.

    BACKGROUND Antimicrobial resistance (AMR) is a global health emergency, disproportionately impacting sub-Saharan Africa where fragmented laboratory information systems (LIS) and inconsistent antimicrobial susceptibility testing (AST) practices limit both clinical decision-making and surveillance capacity. At the University Teaching Hospital of Butare (CHUB) in Rwanda, a baseline Laboratory Assessment of Antibiotic Resistance Testing Capacity (LAARC) identified systemic gaps, including 0% AST panel standardization, 17% cumulative antibiogram generation capacity, and no enforcement of testing quality rules. A standards-based digital infrastructure integrating CLSI- and EUCAST-compliant AST panels into OpenClinic GA with bidirectional WHONet export was implemented in 2024. The implementing study expressly deferred quantitative key performance indicator (KPI) evaluation to allow sufficient post-implementation observation time. OBJECTIVE To quantify the impact of the implemented infrastructure on five KPI domains: (1) AST data capture volume and specimen throughput; (2) data standardization and ease of analysis; (3) laboratory turnaround time (TAT); (4) testing quality, including detection and resolution of specimen-antibiotic incompatibilities, method violations, and intrinsic resistance violations; and (5) antimicrobial resistance (AMR) profiles, including appropriate use of screener discs. METHODS A retrospective pre-post study compared Q1 2024 (pre-implementation; n=505 culture-positive specimens, legacy LIS export) with Q1 2026 (post-implementation; n=3,669 specimens, WHONet-format export) at CHUB. Outcomes included specimen throughput, nomenclature and data structure standardization, TAT (specimen receipt to results release, days), testing quality flags (Nitrofurantoin/Nalidixic acid on non-urine specimens; vancomycin by disc diffusion on staphylococci; ampicillin on intrinsically resistant Enterobacteriaceae), screener disc utilization (Pefloxacin, Cefoxitin), and resistance rates for key pathogens against CLSI 2024 breakpoints. RESULTS Specimen throughput increased 7.3-fold (+626%). Unique organism names decreased from 76 to 39 (-49%), with 11 non-standard spellings of Escherichia coli alone pre-implementation reduced to one WHO-standard entry. All 7,465 post-implementation records carried CLSI 2024 annotations versus 0% pre-implementation. Critical data-analysis fields, age categories, department, TAT timestamps, WHONET antibiotic codes, absent pre-implementation were fully present post-implementation. Pre-implementation errors included: 6 instances of Nitrofurantoin or Nalidixic acid on non-urine specimens, 4 instances of ampicillin on intrinsically resistant Enterobacteriaceae (including 1 spurious susceptible result), and 44 vancomycin results by disc diffusion on staphylococci and streptococci (16 on Staphylococcus aureus), an unreliable method per CLSI. All resolved to zero post-implementation. Screener disc use was transformed: Pefloxacin (fluoroquinolone surrogate for Enterobacteriaceae) was absent pre-implementation and introduced in 95 tests post-implementation; Cefoxitin (MRSA surrogate) was used without a systematic inferential framework pre-implementation (n=81, no inferential display) and formalised under the screener protocol post-implementation (n=33, MRSA rate 24.2%). Median TAT from specimen receipt to results release was 2.80 days (IQR 2.03-3.77). Among key pathogens, Escherichia coli ciprofloxacin resistance was 54.2% and ceftriaxone resistance 42.2%, while carbapenem susceptibility was preserved (imipenem resistance 1.5%). CONCLUSIONS Implementation of a CLSI/EUCAST-compliant digital AST and surveillance infrastructure at CHUB produced measurable, clinically meaningful improvements across all five KPI domains, yielding CHUB's first institution-wide cumulative antibiogram in GLASS-compatible WHONet format. These results fulfill the deferred quantitative evaluation and provide a replicable evidence base for tertiary institutions across sub-Saharan Africa. INTERNATIONAL REGISTERED REPORT RR2-10.2196/82727

  • Open Access

    Rwanda’s lessons for strengthening Africa’s response to current Marburg virus disease outbreaks

    by Claude Mambo Muvunyi, Pierre Gashema, Eric Seruyange, Theogene Twagirumugabe, Isabelle Mukagatare, Patrick Gad Iradukunda, Radjabu Bigirimana, Emmanuel Edwar Siddig, Edson Rwagasore, Jean de Dieu Harelimana, et al.


  • Open Access

    Digital Infrastructure for Antimicrobial Susceptibility Testing and Surveillance: A CLSI and EUCAST-Based Model for Resource-Limited Settings

    by Djibril Mbarushimana, Taofeek Tope Adegboyega, Gatera Jean Damascene, Muritala Issa Bale, Buregeya Jean Damascene, Kayitesi Marie Francoise, Itangishaka Innocent, Rugamba Alexis, Rasheed Omotayo Adeyemo, Bagirinshuti Issa, et al.

    Background: Antimicrobial resistance (AMR) poses a significant global health threat, requiring effective antimicrobial susceptibility testing (AST) and surveillance systems. At the University Teaching Hospital of Butare (CHUB) in Rwanda, a baseline Laboratory Assessment of Antibiotic Resistance Testing Capacity (LAARC) identified critical gaps in the Laboratory Information System (LIS), including low capture rates for culture observation (60%) and AST data (25%), no standardization of AST panels (0%), and limited cumulative antibiogram generation (17%). Existing AMR surveillance platforms, such as the Information System for Monitoring Antimicrobial Resistance by the World Health Organization (WHO) Collaborating Center for Surveillance of Resistance to Antimicrobial Agents (WHONET), and the District Health Information System, operate as standalone systems separate from clinical workflows, which limits their real-time clinical utility. Objective: This study aimed to develop an enhanced, web-based LIS integrated within routine clinical care to improve AST reliability, enable real-time AMR surveillance at CHUB, and provide a scalable model for subnational and national surveillance networks in resource-limited settings, supporting antimicrobial stewardship. Methods: We developed an enhanced LIS using the OpenClinic GA, the current open-source hospital information system at CHUB, integrating Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines, and leveraging metadata from the AMR for R package, WHONET resources, and EUCAST Expert Rules. An agile development approach was used, incorporating a custom database schema, Java-based application programming interfaces (APIs), and web-based user interfaces. The system was designed to support minimum inhibitory concentration (MIC) and disk diffusion (DD) methods, automate result interpretation with color-coded outputs, WHO Access, Watch, Reserve (AWaRe)–based cascade reporting, and enable data export to WHONET for global surveillance. Results: The enhanced LIS improved AST data capture and standardization, providing reliable, automated result interpretation and real-time AMR surveillance capabilities. The system’s web-based architecture enables scalability through centralized deployment, allowing multiple facilities simultaneous access. Unlike standalone surveillance tools, the enhanced LIS integrates AST within electronic medical records, maintaining clinical information continuity from specimen registration through result reporting. The system supports immediate clinical decision through AWaRe–based cascade reporting, and automated resistance phenotype detection, followed by standardized WHONET-compatible exports for public health surveillance. Conclusions: This scalable, LIS model demonstrates the feasibility of implementing standards-based AMR informatics in resource-limited settings. By embedding surveillance within clinical workflows rather than treating it as a separate downstream activity, the system maximizes data quality and clinical relevance while minimizing staff burden. The centralized web-based architecture provides inherent scalability from facility to national levels, eliminating data fragmentation and ensuring metadata consistency across networks. Long-term sustainability requires continuous user training, designated personnel for metadata maintenance, local IT capacity building, and funding mechanisms beyond donor dependency. This model provides a practical roadmap for national digital stewardship programs, supporting both immediate patient care and long-term public health surveillance goals.


  • Variations in the terminal branches of the brachial plexus in humans. A cadaveric study

    by P. Ndahimana, S. Habumuremyi, C. Niyibigira, V.B. Archibong, A. Okesina, T. Twagirumugabe, J. Gashegu


  • Open Access

    Access to Limited Critical Care and Risk of Mortality in Rwanda: A Prospective Cohort Study

    by Alex Mezei, Donatien Hitayezu, Tyler Gilman, Jeffrey Bone, Celestin Hategaka, Srinivas Murthy, Marla McKnight, Theogene Twagirumugabe

    IMPORTANCE: There is a large discrepancy between need and access to critical care in low- and middle-income countries. Little is known about what subgroups of patients are being prioritized for critical care. OBJECTIVES: The primary objective was to assess what clinical, demographic, and socioeconomic variables were associated with timely ICU admission. Secondary objectives included determining the rate of ICU admission among patients who met admission criteria, inpatient mortality, and length of stay. DESIGN: Prospective cohort study. SETTING AND PARTICIPANTS: All adult patients meeting ICU admission criteria at the University Teaching Hospital of Butare, Huye, Rwanda. MAIN OUTCOMES AND MEASURES: The primary outcome was the proportion of patients admitted to ICU within 24 hours of being identified as critically ill. A multivariable logistic regression model was used to assess whether clinical, demographic, or socioeconomic factors are associated with timely ICU admission. Secondary outcomes were the proportion of patients admitted to ICU at any time, inpatient mortality, and length of stay. RESULTS: Three hundred eighteen patients were enrolled between January 24, 2024, and June 3, 2024. Eighty-eight (27.7%) were admitted to ICU within 24 hours. Requiring ICU for postoperative recovery (odds ratio [OR], 8.21; 95% CI, 3.64–19.8), obstetric patients (OR, 2.43; 95% CI, 0.92–6.41), and ICU bed availability (OR, 1.26; 95% CI, 1.02–1.55) increased the odds of timely ICU admission in multivariable analysis. Socioeconomic status, gender, and social connections had minimal association with ICU admission, with wide CIs. The inpatient mortality rate was 44.0% and average length of stay was 14 days. CONCLUSIONS AND RELEVANCE: Obstetric and postoperative patients are prioritized for ICU admission. There is a large unmet need for critical care in Rwanda, and mortality among critically ill patients is high.

  • Open Access

    The New Global Definition of ARDS

    by Theogene Twagirumugabe


  • Open Access

    Genomic characterization uncovers transmission dynamics of Marburg Virus in Rwanda following a single zoonotic spillover event

    by Yvan Butera, Leon Mutesa, Edyth Parker, Raissa Muvunyi, Esperance Umumararungu, Alisen Ayitewala, Jean Pierre Musabyimana, Alhaji Olono, Placide Sesonga, Olusola Ogunsanya, et al.

    The ongoing outbreak of Marburg virus disease (MVD) in Rwanda marks the third largest historically, though it has exhibited the lowest fatality rate. Genomic analysis has identified a lineage with limited internal diversity most closely related to a genome sequence from a sporadic case sampled in 2014 in Uganda, though the lineages have diverged from a common ancestor that was circulating for decades in the animal reservoir. Notably, the data also provide evidence that the outbreak resulted from a single zoonotic transmission event with limited human-to-human transmission, rather than multiple independent zoonotic transmission events. The Rwandan MVD outbreak prompted a thorough investigation that included contact tracing, clinical assessment, travel history, sequencing, and serology testing, to trace the virus’s origin. Results of investigations linked the index case to a mining cave inhabited by Rousettus aegyptiacus (the Egyptian fruit bat), where three individuals tested seropositive for IgG and IgM, further supporting the zoonotic origin of the outbreak through human-animal interactions.


  • Open Access

    Critical Care ATLAS

    by Kelsey D. Sack, Chandrashish Chakravarty, Juliana Carvalho Ferreira, Daniela Helena Machado Freitas, Chris McGrath, Mark E. Mikkelsen, Matteo Di Nardo, Elisabeth Riviello, Michael Root, Jon A. Silversides, et al.